Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?
Authors:
- 1 February 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 33 (1) , 17-23
Abstract
Purpose of review: The association between atrial fibrillation and stroke is firmly established, and anticoagulation reduces stroke risk in patients with atrial fibrillation. However, the role of anticoagulation in very brief durations of atrial fibrillation (subclinical atrial fibrillation) is an area of controversy. Recent findings: Stroke risk increases alongside burden of atrial fibrillation. Ongoing trials will clarify if 24 h or less of atrial fibrillation on extended monitoring necessitates lifelong anticoagulation. Trials examining empiric anticoagulation for individuals with ESUS did not demonstrate benefit over antiplatelet agents. However, hypothesis-generating sub-analyses suggest that certain at-risk groups may benefit. Atrial cardiopathy is associated with subclinical atrial fibrillation and research examining anticoagulation after ESUS in this population is underway. Summary: Stroke risk increases alongside burden of ectopic atrial activity. However, this risk may in part be because of prothrombotic dysfunction associated with atrial cardiopathy in addition to the arrhythmia itself. The minimal amount of subclinical atrial fibrillation to warrant anticoagulation for stroke prevention, and how this may be modified by the total duration of monitoring, will be clarified by the results of ongoing clinical trials. Currently research will also help identify whether a select group of ESUS patients who have structural and electrophysiological markers of atrial cardiopathy warrant anticoagulation for secondary prevention.Keywords
This publication has 44 references indexed in Scilit:
- Stepwise Screening of Atrial Fibrillation in a 75-Year-Old PopulationCirculation, 2013
- Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERTHeart Rhythm, 2012
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and StrokeCirculation, 2010
- The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke RiskCirculation: Arrhythmia and Electrophysiology, 2009
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet TherapyJACC, 2007
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Duration of atrial fibrillation and imminence of stroke: the Framingham study.Stroke, 1983